NH TherAguix announces the arrival of Dr. Olivier de Beaumont as Chief Medical Officer

,
Meylan, France, September 9th, 2022 NH TherAguix ("NHT"), a French clinical biotech specialized in the development of innovative nanomedicines for the treatment of cancer by radiotherapy, announces today the arrival of Dr. Olivier de Beaumont…

Partenariat local sur la plateforme TSIAS dédiée au nettoyage ultra-propre de dispositifs médicaux

,
ECP, à Moirans, mise sur le développement du projet TSIAS (Traitements de Surfaces Innovants pour Application à la Santé). Cette plateforme de R&D se prépare à accueillir des équipements proposant des technologies innovantes en termes…

Carroucell Raises €1.5 Million to Introduce Breakthrough Microcarriers and Customizable Processes to Cell and Gene Therapy Market

,
Funding Consist of Series A Financing from Novalis Biotech and Crédit Agricole des Savoie, as well as support from Bpifrance Grenoble, France, September 7, 2022 -- Carroucell, the microcarrier supplier for cell culture in bioreactor, announced…